Jin Mou, MD, PhD

Dr. Jin Mou is the Implementation Science & Research Development Officer at Binaytara and is the first core member leading the development of the Binaytara Cancer Research Institute. Dr. Mou received her medical training from West China University of Medical Sciences, and Ph.D. in Public Health in Hong Kong. She has broad training in public health, evidence-based health care, clinical epidemiology, and health economics. Dr. Mou’s research spectrum extends from migrant heath, emerging infectious diseases to chronic diseases, patient-centered outcomes, and screening of complex chronic conditions including cancer. She has studied breast cancer screening at Cambridge University, UK, and served on the Hong Kong Breast Cancer Screening Review Board. During her post-doctoral training at the University of British Columbia, she completed the International Cancer Benchmarking Partnership Project (ICBP Module 3, BC Section I; BC Cancer Agency, Canada and Cancer Research, UK), looking specifically at the role of primary care in diagnosing cancer. She also worked on colorectal cancer screening data (~ 1.5 million patients) with experts from McGill University (CIHR grant, Canada). Dr. Mou’s recent work involves studies funded by NCI (1UG1CA189952), NIH (R01DK076608), USCDC (Special Interest Project U48DP006398-02-00), Patient-Centered Outcomes Research Institute (PCORI) (P2P) and industries (BioMarin, Merck). Dr. Mou is an active peer reviewer or consultant for PCORI, NAPCRG, the US Department of Labor and many health research journals. She serves PLOS Global Public Health as a Scientific Editor and is a Fellow of The American College of Epidemiology. Dr. Mou is passionate about working with patient communities, clinicians, and other stakeholders. She believes that good research leads to better practice. At IJCCD, she will support the editorial board’s work as a clinical epidemiologist and researcher with expertise in evidence-based medicine, public health and statistics.